Efficacy and safety of elinzanetant in vasomotor symptoms associated with menopause: A meta-analysis of randomized controlled trials
EndocrinologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- European journal of obstetrics, gynecology, and reproductive biology
- Publicado em
- 30 jan 2025
- Citações
- 3
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of elinzanetant in vasomotor symptoms associated with menopause: A meta-analysis of randomized controlled trials
Milene Vitória Sampaio Sobral, Paula Rocha, Livia Kneipp Rodrigues, Abner Mácola Pacheco Barbosa, Naila Camila da Rocha, Clara de Andrade Pontual Peres, Claudio Lucca Lima Furtado, Danieli Pereira da Silva, Marina Ayabe Gomes de Moraes, Veronica Alvarez-Galiana
Descritores MeSH
- Vasomotor System
- Menopause
- Hot Flashes
- Middle Aged
- Estradiol
- Quality of Life
- Randomized Controlled Trials as Topic
- Progesterone
- Female
- Humans
Veja também
Estudos relacionados
- Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy
- Elinzanetant: Efficacy and safety in the management of vasomotor symptoms in postmenopausal women, a systematic review and meta-analysis with grading of recommendations assessment, development, and evaluation assessment
- Pharmacological Treatments for Menopausal Vasomotor Symptoms: A Systematic Review and Bayesian Network Meta-Analysis of Efficacy and Safety
- Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis